Microbiology or host-response markers, or both, for optimal patient management?

In their study entitled “Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia”, Dr. Self and colleagues investigated a relevant daily problem in pulmonary infections, namely the search for better tools to identify the etiology of a community-acquired pneumonia (CAP) (1).